What does this mean for pharma?
By running digital services on the MyTherapy OS, pharma benefits from a platform that has been developed over hundreds of iterations and is maintained with regular updates. Running modules on the MyTherapy OS rather than building from the ground up helps cut time-to-market, improves pharma’s RoI, and makes scaling globally more cost-effective. The result is a fast and flexible implementation and instant access to a worldwide user base.